Contact Us
24th March 2022
Blog: World TB Day 2022

WHO’s World TB Day is observed on March 24 each year to raise public awareness and understanding about one of the world’s deadliest infectious killers – TB and it’s devastating health, social and economic impact on people around the world.

The theme for 2022 is Invest to End TB – Save Lives.

In the current round of projects, Bloomsbury SET have provided £72,000 of funding to the project “Drug Discovery against MDR TB: Development of preclinical data Pack, IP protection and patenting strategy“, led by Professor Giancarlo Biagini (LSTM).

The Bloomsbury SET award will support completion of pre-clinical data packs and IP filing, towards progression of one or more series to candidate declaration. The investigators’ ongoing activities and existing partnerships in drug discovery and extensive collaborative networks will bring to bear significant added value to this project.

In the previous Bloomsbury SET funding call, £350,000 was awarded to the project “Bacteriophage technology: rapid point-of-care detection and antibiotic resistance profiling of tuberculosis infections” led by Dr Ben Swift (RVC).

This project aimed to develop a novel diagnostic platform technology that has the potential to revolutionise the detection of TB and other pathogens in humans and animals.

In addition, a total £430,000 was awarded to other TB related projects:
Multi-disciplinary research for the strategic and translational development of late-stage tuberculosis vaccine candidates” by Professor Richard White (LSHTM), Dr Rebecca Harris (LSHTM), Dr Miqdad Asaria (LSE) and Professor Janet Seeley (LSHTM)
and “Using system dynamics modelling for collaborative, evidence-based design of interventions to reduce tuberculosis transmission in South African health facilities” by Professor Alison Grant (LSHTM), Dr Justin Parkhurst (LSE), Prof Anna Vassall (LSHTM), Dr Fiammetta Bozzani (LSHTM) and Dr Aaron Karat  (LSHTM).

The Bloomsbury SET is proud to continue to support research into diagnostic and treatment for tuberculosis. TB remains one of the world’s deadliest infectious killers. Each day, over 4100 people lose their lives to TB and close to 28,000 people fall ill with this preventable and curable disease. Global efforts to combat TB have saved an estimated 66 million lives since the year 2000